Rheumatology Unit, Department of Internal Medicine, Penang General Hospital, Penang, Malaysia.
Int J Rheum Dis. 2022 Feb;25(2):131-139. doi: 10.1111/1756-185X.14269. Epub 2021 Dec 23.
To evaluate the performance of the 2019 European League Against Rheumatism/American College of Rheumatology (EULAR/ACR) classification criteria for systemic lupus erythematosus (SLE) in a multi-ethnic Malaysian cohort and to compare it against the Systemic Lupus International Collaborating Clinics (SLICC) 2012 and ACR 1997 criteria.
We conducted a retrospective observational study of 205 patients with a diagnosis of SLE and 100 controls who formed the validation cohort. The sensitivity and specificity of the three classification criteria were evaluated and a further sub-analysis was performed in patients with early disease and among the various ethnicities.
The sensitivities and specificities of the three classification criteria are as follows: EULAR/ACR (90.8%; 94%), SLICC 2012 (96.1%; 94%), and ACR 1997 (82%; 96%). Among patients with early disease, the sensitivity of the SLICC 2012 was higher than that of EULAR/ACR and ACR 1997 (98% vs 94% and 86%); however, the specificity of EULAR/ACR and ACR 1997 were similar (95.2%) and higher than the SLICC 2012 (93.5%). The SLICC 2012 had higher sensitivity than that of the EULAR/ACR among the Malays (94% vs 90%), Chinese (98% vs 90%), and Indians (100% vs 95%). The specificity of the EULAR/ACR and SLICC 2012 were similar in the Malay and Chinese (93.3% each, and 92% vs 94.6%).
The EULAR/ACR performed well in our cohort. The EULAR/ACR and SLICC 2012 showed higher sensitivity than the ACR 1997, and the EULAR/ACR showed similar specificity to the ACR 1997 and SLICC 2012 overall, in early disease, and across the different ethnicities.
评估 2019 年欧洲抗风湿病联盟/美国风湿病学会(EULAR/ACR)系统性红斑狼疮(SLE)分类标准在马来西亚多民族队列中的表现,并将其与系统性红斑狼疮国际合作临床组织(SLICC)2012 年和 ACR 1997 年标准进行比较。
我们对 205 例确诊为 SLE 的患者和 100 例对照组患者进行了回顾性观察性研究,这些患者构成了验证队列。评估了三种分类标准的敏感性和特异性,并在早期疾病患者和不同种族患者中进行了进一步的亚分析。
三种分类标准的敏感性和特异性如下:EULAR/ACR(90.8%;94%)、SLICC 2012(96.1%;94%)和 ACR 1997(82%;96%)。在早期疾病患者中,SLICC 2012 的敏感性高于 EULAR/ACR 和 ACR 1997(98%比 94%和 86%);然而,EULAR/ACR 和 ACR 1997 的特异性相似(95.2%),高于 SLICC 2012(93.5%)。在马来人、华人、印度人患者中,SLICC 2012 的敏感性高于 EULAR/ACR(94%比 90%、98%比 90%和 100%比 95%)。EULAR/ACR 和 SLICC 2012 在马来人和华人中的特异性相似(分别为 93.3%和 92%比 94.6%)。
EULAR/ACR 在我们的队列中表现良好。EULAR/ACR 和 SLICC 2012 与 ACR 1997 相比具有更高的敏感性,而 EULAR/ACR 在早期疾病和不同种族中与 ACR 1997 和 SLICC 2012 具有相似的特异性。